Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes
Angelo Maria Patti, Rosaria Vincenza Giglio, Alberto Allotta, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1362-1362
Open Access | Times Cited: 17

Showing 17 citing articles:

Modern Management of Cardiometabolic Continuum: From Overweight/Obesity to Prediabetes/Type 2 Diabetes Mellitus. Recommendations from the Eastern and Southern Europe Diabetes and Obesity Expert Group
Andrej Janež, Emir Muzurović, Paweł Bogdański, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 9, pp. 1865-1892
Open Access | Times Cited: 11
Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies
Khamis Al-Hashmi, Rosaria Vincenza Giglio, Anca Pantea Stoian, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 9
Effects of Once-Weekly Semaglutide on Cardiovascular Risk Factors and Metabolic Dysfunction-Associated Steatotic Liver Disease in Japanese Patients with Type 2 Diabetes: A Retrospective Longitudinal Study Based on Real-World Data
Hisayuki Katsuyama, Mariko Hakoshima, Emika Kaji, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1001-1001
Open Access | Times Cited: 6
Anti-inflammatory effect of semaglutide: updated systematic review and meta-analysis
Walter Masson, Martín Lobo, Juan Patricio Nogueira, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 5
Physician Perceptions of the Safety and Efficacy of GLP-1 Receptor Agonists: Underestimation of Cardiovascular Risk Reduction and Discrepancies with Clinical Evidence
Srikanth Krishnan, Pratyaksh K. Srivastava, Jayram Attaluri, et al.
Journal of Cardiovascular Development and Disease (2025) Vol. 12, Iss. 1, pp. 19-19
Open Access
Different formulations of semaglutide and oxidative stress in subjects with type 2 diabetes and MASLD: an open-label, real-life study
Giovanni Petralli, Alice Del Zoppo, Chiara Rovera, et al.
Acta Diabetologica (2025)
Closed Access
Long-term effects of different hypoglycemic drugs on carotid intima-media thickness progression: a systematic review and network meta-analysis
Qianyu Lv, Yingtian Yang, Yanfei Lv, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 4
Bile acids and incretins as modulators of obesity-associated atherosclerosis
Andrijana Kirsch, Juergen Gindlhuber, Diana Zabini, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 11
Open Access
Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Intima-Media Thickness: Systematic Review and Meta-Analysis
Abolfazl Akbari, Shiva Hadizadeh, Leida Heidary
Journal of Diabetes Research (2024) Vol. 2024, pp. 1-14
Open Access | Times Cited: 3
Mechanisms of Non-alcoholic Fatty Liver Disease and Beneficial Effects of Semaglutide: A Review
Sultan A. Alfawaz, Abdulhadi S. Burzangi, Ahmed Esmat
Cureus (2024)
Open Access | Times Cited: 3
Response to semaglutide of non-drinker subjects with type 2 diabetes
Giovanni Petralli, Francesco Raggi, Alice Del Zoppo, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Semaglutide for management of obesity in adolescents: efficacy, safety, and considerations for clinical practice
Megan O. Bensignor, Silva Arslanian, Mary Ellen Vajravelu
Current Opinion in Pediatrics (2024) Vol. 36, Iss. 4, pp. 449-455
Closed Access | Times Cited: 2
The effect of SGLT2 inhibitors and GLP1 receptor agonists on arterial stiffness: A meta-analysis of randomized controlled trials
Evangelos C. Rizos, Christos F. Tagkas, Alexandros-Georgios I. Asimakopoulos, et al.
Journal of Diabetes and its Complications (2024) Vol. 38, Iss. 7, pp. 108781-108781
Closed Access | Times Cited: 2
The importance of arterial stiffness in pediatric patients with type 1 diabetes mellitus: What's new?
Evangelos C. Rizos, Evangelia Ntzani, Imran Rashid Rangraze, et al.
Journal of Diabetes and its Complications (2024) Vol. 38, Iss. 11, pp. 108877-108877
Closed Access | Times Cited: 2
Two sides of the same coin: Non-alcoholic fatty liver disease and atherosclerosis
Bo Zhu, Hao Wu, Kathryn Li, et al.
Vascular Pharmacology (2023) Vol. 154, pp. 107249-107249
Closed Access | Times Cited: 6
From diabetes to diverse domains: the multifaceted roles of GLP-1 receptor agonists
Bhavarth P. Dave, Mehul R. Chorawala, Ishika V Shah, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
A Comprehensive Review of the Role of GLP-1 Agonists in Weight Management and Their Effect on Metabolic Parameters Such as Blood Glucose, Cholesterol, and Blood Pressure
Ushna Gul, Thazin Nwe Aung, Mehwish Martin, et al.
Cureus (2024)
Open Access
Page 1

Scroll to top